Prevalence of Metabolic Syndrome and Associated Factors in a Cohort of Individuals With Treatment-Resistant Depression: Results From the FACE-DR Study.
Fiche publication
Date publication
octobre 2019
Journal
The Journal of clinical psychiatry
Auteurs
Membres identifiés du Cancéropôle Est :
Pr HAFFEN Emmanuel
Tous les auteurs :
Godin O, Bennabi D, Yrondi A, Richieri R, D'Amato T, Bellivier F, Bougerol T, Horn M, Camus V, Courtet P, Doumy O, Genty JB, El-Hage W, Haesebaert F, Holtzmann J, Lancon C, Leboyer M, Llorca PM, Maruani J, Molière F, Samalin L, Schmitt L, Stephan F, Vaiva G, Aouizerate MWB, Haffen E,
Lien Pubmed
Résumé
The aim of this study was to estimate the prevalence of metabolic syndrome (MetS) and its components in a cohort of French patients with treatment-resistant depression (TRD) and to determine correlations with sociodemographic, clinical, and treatment-related factors.
Référence
J Clin Psychiatry. 2019 Oct 15;80(6):